Recombinant Fusion Proteins
- Name
- Recombinant Fusion Proteins
- Accession Number
- DBCAT002953
- Description
Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.
- Drugs
Drug Drug Description Tagraxofusp A CD123-directed cytotoxin used to treat blastic plasmacytoid dendritic cell neoplasm. Alefacept A recombinant fusion protein that binds CD2 and is used treat moderate to severe plaque psoriasis. rGLP-1 Investigated for use/treatment in congestive heart failure and diabetes mellitus type 2. PRO-542 Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications. Efanesoctocog alfa A recombinant DNA-derived, Factor VIII concentrate indicated for routine prophylaxis, on-demand treatment and control of bleeding episodes, and perioperative management of bleeding in patients with hemophilia A. - Drugs & Drug Targets